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Although high hydrostatic pressure (HHP) is an interesting parameter to be applied in 28 
bioprocessing, its potential is currently limited by the lack of bacterial chassis capable 29 
of surviving and maintaining homeostasis under pressure. While several efforts have 30 
been made to genetically engineer microorganisms able to grow at sublethal pressures, 31 
there is little information for designing backgrounds that survive more extreme 32 
pressures. In this investigation, we analysed the genome of an extreme HHP-resistant 33 
mutant of E. coli MG1655 (designated as DVL1), from which we identified four 34 
mutations (in the cra, cyaA, aceA and rpoD loci) causally linked to increased HHP 35 
resistance. Analysing the functional effect of these mutations we found that the coupled 36 
effect of downregulation of cAMP/CRP, Cra and the glyoxylate shunt activity, together 37 
with the upregulation of RpoH and RpoS activity, could mechanistically explain the 38 
increased HHP resistance of the mutant. Using combinations of three mutations, we 39 
could synthetically engineer E. coli strains able to comfortably survive pressures of 600-40 
800 MPa, which could serve as genetic backgrounds for HHP-based biotechnological 41 
applications.  42 
 43 
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1. Introduction 52 
High hydrostatic pressure (HHP) is an important parameter in the biosphere that ranges 53 
from atmospheric pressure (0.1 MPa) on the earth’s surface to 110 MPa in the deepest 54 
part of the ocean (Mariana Trench), and likely even higher pressures in the deep 55 
subsurface that might still be colonized with microorganisms (Oger and Jebbar, 2010; 56 
Peoples et al., 2019). As described by the thermodynamic principle of Le Châtelier and 57 
Braun, HHP can change the organization and function of biomolecules as well as the 58 
rate and direction of enzymatic reactions (Eisenmenger and Reyes-De-Corcuera, 2009; 59 
Winter and Dzwolak, 2005). Consequently, several industrial applications are emerging 60 
or being envisaged from imposing HHP on biological systems (Aertsen et al., 2009; 61 
Mota et al., 2013). As such, HHP has been implemented in non-thermal food processing 62 
for inactivating undesirable enzymes and microorganisms, while retaining the sensorial 63 
qualities of the food (Wang et al., 2016). On the other hand, pressure resistance is a 64 
desirable trait in starter or probiotic cultures added in foods that need to fulfil their 65 
functions after HHP processing (da Cruz et al., 2010; Speranza, 2020). HHP-mediated 66 
modulation of enzymatic reactions and/or substrate availability can also be exploited for 67 
accelerating reaction rate, generating new products and/or inhibiting undesirable ones 68 
(Eisenmenger and Reyes-De-Corcuera, 2009; Oey, 2016). However, enzymes 69 
supporting desired reactions need themselves to be structurally stable and functional 70 
under pressure, which could be accomplished by engineering the enzyme or sheltering it 71 
in a HHP-resistant cellular environment that would manage to preserve enzyme activity 72 
(Huang et al., 2016; Ichiye, 2018). Moreover, there is growing interest in using 73 
pressure-tolerant strains for governing rate and direction of biosynthetic pathways in 74 
microbial fermentation and bioremediation of deep sea oil spills (Mota et al., 2018; 75 










Further exploitation of HHP technology for such biotechnological applications however 78 
would require a better understanding of the impact of pressure on bacterial physiology 79 
and the corresponding (stress) response and adaptation mechanisms. In fact, this would 80 
allow inferring genetic strategies to synthetically engineer HHP compatible or resistant 81 
microbial chassis or molecular strategies to preserve enzyme functionality under or after 82 
HHP exposure. Such insights can in part be gathered from piezophilic microorganisms 83 
that thrive in the deep sea, and that can grow at pressures of up to 130 MPa (Oger and 84 
Jebbar, 2010). However, these extremophiles are not adapted to HHP alone, but rather 85 
to the deep-sea environment as a whole (Hay et al., 2009; Ichiye, 2018). Together with 86 
the lack of genetic tractability (Zhang et al., 2015b), this makes the identification and 87 
validation of HHP adaptations more complex. Moreover, strategies for growth tolerance 88 
under sublethal HHP conditions do not necessarily coincide with survival mechanisms 89 
at higher pressures (Follonier et al., 2012; Gayán et al., 2017b). Another important 90 
source of information, however, can stem from mesophiles that, through directed 91 
evolution, became forced to very selectively acquire HHP growth tolerance (Marietou et 92 
al., 2015) or extreme HHP resistance (Karatzas et al., 2007; Van Boeijen et al., 2011; 93 
Vanlint et al., 2012).  94 
 95 
In the latter context, Escherichia coli seems particularly suited to acquire HHP 96 
resistance. In fact, not only is there already quite some variability in HHP resistance 97 
among different E. coli solates, directed evolution efforts have also managed to endow 98 
this bacterium with extreme HHP resistance (Hauben, 1997; Vanlint et al., 2011; 99 
Vanlint et al., 2012). As such, a mutant of E. coli K12 MG1655 (designated as DVL1) 100 









exposure of the strain to progressively intensifying HHP shocks with intermittent 102 
resuscitation and outgrowth (Vanlint et al., 2011). On the contrary, closely related 103 
strains, such as Salmonella enterica, Shighella flexneri and Yersinia enterocolitica, 104 
appeared less fit to spontaneously acquire HHP resistance under the same selective 105 
pressure (Vanlint et al., 2012).  106 
 107 
Analysis of HHP-resistant E. coli isolates so far indicates that mutants with an 108 
upregulated RpoS-mediated stress response are often selected (Vanlint et al., 2013b), 109 
which coincides with previous observations on the crucial role of this sigma factor for 110 
HHP resistance (Charoenwong et al., 2011; Robey et al., 2001). More recently, 111 
acquiring loss-of-function mutations compromising cAMP/CRP regulation has been 112 
reported as an alternative evolutionary route towards increased HHP resistance, 113 
regardless of basal cellular RpoS activity (Gayán et al., 2017a). Although we have 114 
subsequently shown that downregulating cAMP/CRP activity and upregulating RpoS 115 
response boosted pressure resistance of E. coli, this improvement was still far from the 116 
extensive levels of HHP resistance acquired by some spontaneous mutants such as 117 
DVL1 (Gayán et al., 2017a).  118 
 119 
In this study, we therefore aimed to elucidate the genetic basis of the acquired HHP 120 
resistance in DVL1, by first comparing the genome sequences of the evolved mutant 121 
and its parental strain and then examining the contribution of identified mutations to the 122 
HHP resistance phenotype by synthetically reconstructing each of them and their 123 
combinations in the parental background. As a result, E. coli chassis with extreme 124 
resistance to high pressures (i.e., 600–800 MPa) were engineered with the minimally 125 











2. Material and methods 129 
2.1. Whole genome sequencing 130 
High-quality genomic DNA of E. coli  DVL1 (Vanlint et al., 2011) and its MG1655 131 
parental strain (Blattner et al., 1997) was isolated from overnight cultures in Lysogeny 132 
Broth (LB) medium (Miller, 1992) incubated aerobically at 37ºC, using the GeneJET 133 
Genomic DNA Purification Kit (Thermo Fisher Scientific, Waltham, MA, USA). 134 
Paired-end libraries were prepared using the NEBNext Ultra kit and analyzed on the 135 
Agilent BioAnalyzer. Sequencing was performed with an Illumina MiSeq sequencer 136 
(VIB Nucleomics Core, Belgium), yielding 1,511,848 and 1,823,728 paired-end reads 137 
(150 bp) for the WT and DVL1 strain, respectively. CLC Genomics Workbench version 138 
7.5.1 (CLC Bio, Aarhus, Denmark) was used for analysis of the sequences, as 139 
previously described by Van den Bergh et al. (2016). Following quality assessment of 140 
the raw data, reads were trimmed using quality scores of the individual bases (quality 141 
limit  = 0.01; maximum number of ambiguous bases = 2). Reads shorter than 15 bases 142 
were discarded from the set. Mapping of trimmed reads was performed by the CLC 143 
“Map Reads to Reference” algorithm (mismatch cost = 2; insertion cost = 3; deletion 144 
cost = 3; length fraction = 0.8; similarity fraction = 0.8) using as a reference the E. coli 145 
MG1655 genome (NC_000913.2) (Blattner et al., 1997). Mutations were detected using 146 
the CLC Fixed Ploidy Variant Detection tool (minimum coverage = 10; minimum 147 
frequency = 20%; required significance = 1%) and the InDels and Structural Variants 148 
tool (P-value threshold = 0.0001; maximum number of mismatches = 3; minimum 149 
number of reads = 2). Furthermore, the presence of large deletions or insertions were 150 








Mutations found in both WT and DVL1 strains compared to the reference genome were 152 
discarded. Finally, the identified mutations were further confirmed with Sanger 153 
sequencing analysis, using the primers listed in Table S1. 154 
 155 
2.1. Strain and plasmid construction 156 
The E. coli strains and plasmids used throughout this investigation are listed in 157 
Table S2, while the primers used for constructions are listed in Table S1. LB broth and 158 
agar were routinely used for strain and plasmid construction and when necessary, a final 159 
concentration of 50 μg/ml of kanamycin (Panreac-AppliChem, Darmstadt, Germany), 160 
20 μg/ml of tetracycline (Sigma-Aldrich, St. Louis, MO, USA), 100 μg/ml of ampicillin 161 
(Thermo Fisher Scientific) or 30 μg/ml of chloramphenicol (Sigma-Aldrich) was added 162 
to select for the presence of plasmids or recombined amplicons.  163 
 164 
The mutations found in DVL1 were identically reconstructed in the parental wild-type 165 
(WT) E. coli MG1655 by the dual counter-selection system described by Li et al. 166 
(2013). Firstly, the homologue region containing the target mutation of DVL1 in the 167 
cells of interest, equipped with the plasmid pKD46 (encoding the λ red recombinase 168 
genes behind the araBAD promoter (Datsenko and Wanner, 2000)), was replaced by an 169 
amplicon containing the tetA-sacB marker prepared on E. coli XTL298. In a second 170 
step, counter-selection was used to recombine the te A-sacB cassette with a 171 
PCR product obtained on DVL1 using primers flanking the desired mutation. For the 172 
point mutation located in the 5’ UTR of rpoD gene, the tetA-sacB cassette was inserted 173 
upstream of the point mutation to avoid transcription defects that could affect cell 174 
viability (Baba et al., 2006), and the clones lacking the cassette after the counter-175 










Gene deletions were performed according to the method of Datsenko and Wanner 178 
(2000). Briefly, an amplicon prepared on pKD13 (containing the kanamycin resistance 179 
cassette [nptI]) was recombineered in-frame after the start codon of the target gene of a 180 
pKD46 equipped strain. The kanamycin resistance gene was flanked by frt sites to be 181 
further excised by transiently equipping the strain with the plasmid pCP20 (expressing 182 
the Flp site-specific recombinase (Cherepanov and Wackernagel, 1995)). The rpoD-183 
msfgfp transcriptional fusions were constructed by obtaining a msfgfp-frt-nptI-184 
frt amplicon from the plasmid pDHL1029 (Ke et al., 2016) that was recombineered after 185 
the 3’ end of rpoD. To maximize co-translational activity, the gene 186 
encoding msfgfp was preceded by a strong synthetic ribosome binding site 187 
(BBa_B0034; sequence AAAGAGGAGAA (Elowitz and Leibler, 2000)). The 188 
resistance cassette was subsequently excised by transiently equipping the strains with 189 
pCP20. 190 
 191 
pACYC184-based complementation plasmids were constructed by first amplifying the 192 
cra and aceBA loci of MG1655 (WT) along with their native promoters after primers 193 
phosphorylation by T4 polynucleotide kinase (Thermo Fisher Scientific). Please note 194 
that aceA forms part of the aceBAK operon, and since it is located downstream of aceB 195 
preceded by the operon promoter (Cozzone and El-Mansi, 2005), the aceAB 196 
transcriptional unit was cloned in the same vector. Then, the obtained products were 197 
blunt-ligated (T4 DNA ligase; Thermo Fisher Scientific) to a pACYC184 backbone 198 
(Rose, 1988) obtained by PCR amplification, resulting in pACYC184-craWT (encoding 199 
the MG1655 cra gene under the control of its native promoter) and pACYC184-200 









promoter). Where indicated, the strains were transformed with pACYC184-craWT, 202 
pACYC184-aceBAWT or the corresponding backbone control plasmid (pACYC184 203 
(Rose, 1988)).  204 
 205 
All constructed mutants and plasmids were initially confirmed by PCR with primer 206 
pairs attaching outside of the region where homologous recombination or ligation 207 
occurred (Table S1), and further verified by sequencing (Macrogen, the Netherlands). 208 
 209 
2.3. Determination of HHP resistance 210 
The HHP resistance of E. coli strains was determined in the stationary phase of growth. 211 
Stationary phase cultures were obtained by inoculating 15 ml-test tubes containing 4 ml 212 
of Tryptone Soy Broth (TSB; Oxoid, Basingstoke, UK) with a single colony of each 213 
strain, which were then incubated aerobically with shaking (300 rpm) for 18 h at 37°C 214 
reaching ca. 3 ×109 CFU/ml. When necessary, TSB was supplemented with 215 
chloramphenicol to select for the presence of pACYC184-based vectors (Rose, 1988). 216 
Cells were harvested by centrifugation (4000 g, 5min) and resuspended in an equal 217 
volume of 0.85% KCl (Sigma-Aldrich). A portion of 200 μl of each cell suspension was 218 
individually heat sealed in a sterile polyethylene bag after exclusion of the air bubbles 219 
and subjected to pressure (500–800 MPa) for 15 min in an 8-ml pressure vessel (HPIU-220 
10000, 95/1994; Resato, Roden, The Netherlands), held at 20 °C with an external water 221 
jacket connected to a cryostat. Both the slow pressure increase (100 MPa/min) and the 222 
external water jacket attenuated adiabatic heating during pressure build-up. Finally, 223 
decompression was almost instantaneous. After treatment, samples were aseptically 224 










2.3. Determination of viability and extent of sublethal injury 227 
Samples were serially diluted in 0.85% KCl supplemented with 0.1% bacteriological 228 
peptone water (Oxoid), and subsequently 20 μl of each dilution were spread-plated onto 229 
Tryptone Soy Agar (TSA; Oxoid) plates. When indicated, cells were also recovered on 230 
Violet Red Bile Glucose Agar (VRBGA; Oxoid) as a selective medium to determine the 231 
extent of sublethal injury. After 24 h of incubation at 37°C, plates containing between 232 
around 20 and 200 colonies were counted, so that the limit of quantification was 1,000 233 
CFU/ml. The logarithmic reduction factor was calculated as log (N0/N), in 234 
which N0 and N represent the number of survivors in CFU/ml prior and after treatment, 235 
respectively. The number of sublethal injured cells was calculated by the difference 236 
between the counts on the non-selective (TSA) and the selective medium (VRBGA).  237 
 238 
2.4. Evaluation of acetate usage 239 
To examine the ability of acetate usage, we compared the growth on M9 agar (Miller, 240 
1992) supplemented with acetate (1.0%; Acros Organics, Morris Plains, NJ, USA) or D-241 
glucose (0.5%; Sigma-Aldrich) as the sole carbon source. To this end, stationary phase 242 
cultures were washed twice and diluted 1/100 in M9 salts, from which a 5-μl drop was 243 
spotted on M9-acetate and M9-glucose. After incubation at 37°C for 48 h, growth of 244 
each strain on each medium was scored from ++++ (WT growth) to − (no growth). 245 
 246 
2.5. Measurement of β-galactosidase activity 247 
The β-glactosidase reporter was used to assess the activity of the RpoD sigma factor 248 
(Fischer et al., 1998; Fu et al., 2015), which directs the expression of essential genes for 249 
growth at optimal conditions. The assay was carried out as previously described by 250 









1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG; Acros Organics) for 18 h at 37ºC. 252 
The β-galactosidase activity of permeabilized cells on orth -nitrophenyl-β-galactoside 253 
(ONPG; Acros Organics) cleavage was measured in a Multiskan RC (Thermo 254 
Labsystems, Vantaa, Finland) and expressed in Miller units (MU). 255 
 256 
2.6. Measurement of fluorescent gene reporters 257 
Activity of the RpoS sigma factor (directing the expression of the general stress 258 
response) was quantified through the activity of the bolA promoter (PbolA) using the 259 
pFPV-PbolA-gfp construct (Gayán et al., 2016), since transcription of bolAgene depends 260 
on the RpoS sigma factor (Battesti et al., 2011). Activity of the RpoH sigma factor 261 
(directing the expression of the heat shock response) was measured through the activity 262 
of the dnaK promoter (PdnaK) using the pFPV-PdnaK-gfp construct (Aertsen et al., 2004), 263 
since transcription of the dnaK gene depends on RpoH sigma factor (Roncarati and 264 
Scarlato, 2017). The fluorescence emitted by these reporters was measured in 200 μl of 265 
stationary phase cultures equipped with pFPV-PbolA-gfp or pFPV-PdnaK-gfp using a 266 
Fluoroscan Ascent FL (Thermo 180 Labsystems, Brussels, Belgium). The GFP signal 267 
was measured at an excitation wavelength of 480 nm and an emission wavelength of 268 
520 nm. The obtained fluorescence values were divided by the optical density measured 269 
at 600 nm (OD600) on the same sample to obtain the relative fluorescence units. 270 
Differences in RpoS and RpoH activity were expressed as fold change with respect to 271 
the parental strain. 272 
 273 
To measure expression of the rpoD gene, the rpoD-msfgfp transcriptional fusion was 274 
chromosomally constructed in the cells of interest, and the signal derived from the 275 









Fluorescence microscopy was performed with a Ti-Eclipse inverted microscope (Nikon, 277 
Champigny-sur-Marne, France) equipped with a 60× Plan Apo λ oil objective, a TI-CT-278 
E motorized condenser and a Nikon DS-Qi2 camera. A SpecraX LED illuminator 279 
(Lumencor, Beaverton, USA) was used as a light source. GFP was imaged using a triple 280 
excitation filter (Ex 473/30) and an emission filter (Em 520/35). For imaging, cells were 281 
diluted 1/50 in 0.85% KCl and then placed in 0.85% KCl agarose pads and a cover 282 
glass, as previously described (Cenens et al., 2013). Images were taken using the NIS-283 
Elements AR software (Ver. 4.51; Nikon), using identical acquisition parameters for 284 
images of the strains to be compared. Image analysis was performed with the open 285 
source software MicrobeTracker (Sliusarenko et al., 2011), which estimated average 286 
cellular fluorescence of cell meshes generated after background subtraction. The 287 
average cellular fluorescence, expressed in arbitrary units (AU), was calculated by 288 
dividing the integrated pixel intensities of individual cells by their corresponding areas. 289 
A number of ca. 100 cells were evaluated from each independent culture of each strain.  290 
 291 
2.7. Statistical analysis 292 
Statistical analyses, ANOVA and t-tests, were carried out using the software GraphPad 293 
PRISM 5.0 (GraphPad Software Inc., San Diego, CA, USA), and differences were 294 
regarded as significant when P was ≤ 0.05. All microbial inactivation outcomes shown 295 
in figures correspond to averages and standard deviations calculated from at least three 296 
replicates performed in different working days. Miller and fluorescence data correspond 297 












3. Results 302 
3.1 Whole genome sequencing of DVL1 303 
In order to identify the mutations in E. coli MG1655 strain DVL1 (further referred to as 304 
DVL1) that are potentially linked to its extreme HHP resistance, the whole genome of 305 
the evolved mutant and its MG1655 parent was sequenced, yielding on average 53.5 306 
fold and 44.8 fold coverage, respectively. Comparative analysis revealed a total of 5 307 
mutations across the DVL1 genome, which were all confirmed by Sanger sequencing: 308 
three single-nucleotide polymorphisms (SNPs), a deletion and an insertion (Table 1). 309 
 310 
One of the SNPs was located in the open reading frame (ORF) of the cra gene 311 
(encoding the catabolism repressor-activator), leading to an amino acid (AA) 312 
substitution (Leu56Arg) in the binding domain of the effector metabolite (Vartak et al., 313 
1991). Another was placed in the ORF of the y dH gene (encoding the acrylyl-CoA 314 
reductase), resulting in an AA change (Phe77Val) in the catalytic domain (Sulzenbacher 315 
et al., 2004). The third SNP was found in the intergenic region between dnaG and rpoD 316 
genes (encoding the DNA primase and RNA polymerase sigma factor D [σ70], 317 
respectively), within the 5’ untranslated region (UTR) of rpoD (Lupski et al., 1984; 318 
Yajnik and Godson, 1993). A deletion of 50 bp was found within the ORF of the aceA 319 
gene (encoding the isocitrate lyase), resulting in a frame-shift from position 1,133 bp 320 
and (because of an earlier stop codon) a truncation of the ORF at position 1,179 bp. 321 
Finally, an insertion of 5 bp was found within the ORF of the cyaA locus, resulting in a 322 
frame-shift from position 1,924 bp and (because of an earlier stop codon) a truncation of 323 
the ORF at position 1,953 bp, which would remove the regulatory domain of the CyaA 324 
protein (Park et al., 2006). This latter mutation was already identified in our previous 325 








Table 1. Mutations identified in E. coli DVL1. 327 
 328 





Protein change Function 
88194 ORF of cra SNP T→G Leu56Arg DNA-binding transcriptional dual regulator 
Cra (catabolite repressor-activator), which 
controls many genes encoding enzymes 




and rpoD (5’ 
UTR of rpoD) 
SNP G→A   RNA polymerase sigma factor D (σ70), 
















AA 643 to 650d 
(normal length: 
848 AA) 
Adenylate cyclase, which synthesizes cAMP 












AA 378 to 392d 
(normal length: 
434 AA) 
Isocitrate lyase, involved in the glyoxylate 
cycle. 
SNP: single nucleotide polymorphism; ORF: open reading frame; 5’ UTR: 5’ untranslated region; AA: amino acid. 
aPositions are placed according to the MG1655 reference genome map (NC_000913.2). 
bThe position gives the nucleotide after which the insertion took place. 
cThe positions give, and include, the nucleotides that were deleted. 









3.2. Identification of key mutations for increased HHP resistance  329 
We first aimed to identify the key single mutations for increased HHP resistance by 330 
individually reconstructing each mutant allele de novo in the parental background and 331 
comparing their resistance at different pressure levels (Fig. 1). All the single mutations 332 
significantly (P ≤ 0.05) increased HHP survival of the WT strain, except for the SNP 333 
found in yhdH gene, suggesting that this latter mutation might have trivially hitchhiked 334 
along during the selection of DVL1. However, none of the mutations could on its own 335 
enforce the level of HHP resistance displayed by DVL1.  336 
 337 
The contribution of each mutation to HHP resistance also varied with the applied 338 
pressure. The aceADVL1 mutant showed ca. 1 log cycle lower (P ≤ 0.05) inactivation than 339 
the WT strain at 600 MPa and 700 MPa, but no resistance improvement (P > 0.05) at 340 
800 MPa. The craDVL1 and cyaADVL1 mutants showed the highest HHP resistance at all 341 
pressures, displaying a similar (P > 0.05) increase in resistance at low and high pressure 342 
(on average 2.3 and 1.9 log cycles at 600 MPa and 800 MPa, respectively) compared to 343 
the WT strain. In contrast, the increase in survival of the rpoDDVL1 mutant was larger at 344 
700 MPa and 800 MPa (1.7 and 2.0 log cycles, respectively) than at 600 MPa (1.5 log 345 
cycles), reaching similar levels (P > 0.05) of resistance than the craDVL1 and cyaADVL1 346 









  348 
Figure 1. Inactivation (log [N0/N]) of DVL1, MG1655 (WT) and indicated single and 349 
double synthetic mutants of MG1655 by HHP treatment (15 min) at different pressures 350 
(600 MPa, 700 MPa and 800 MPa). Survivors were recovered on TSA. The dotted line 351 
represents the limit of quantification (1,000 CFU/ml). Letters above each bar allow 352 
strains within the same panel to be statistically compared. Strains are only significantly 353 










Subsequently, we investigated the effect of synthetically combining two of the key 356 
mutations (i.e., craDVL1, cyaADVL1, rpoDDVL1 and aceADVL1) on MG1655 HHP resistance 357 
(Fig. 1). The incorporation of the aceADVL1 allele into the craDVL1 and cyaADVL1 mutants 358 
improved (P ≤ 0.05) their HHP survival by ca. 0.9 log cycles at 700 MPa and 800 MPa, 359 
even though at the latter pressure the aceADVL1 mutation alone could barely provide 360 
HHP protection to the parental strain. However, the strain harbouring the combination 361 
of aceADVL1 and rpoDDVL1 mutations showed the same (P > 0.05) phenotype than the 362 
rpoDDVL1 mutant at all pressures tested. The combination of the mutations that were 363 
most powerful on their own (i.e., [cra/cyaA]DVL1 strain) increased (P ≤ 0.05) HHP 364 
resistance of the single craDVL1 and cyaADVL1 mutants only at 700 MPa and 800 MPa by 365 
ca. 1.3 log cycles. Adding the rpoDDVL1 mutation to the craDVL1 or cyaADVL1 strains, 366 
however, resulted in a much greater improvement (1.7 log cycles on average at 700 367 
MPa and 800 MPa). The largest effect was observed in the [cyaA/rpoD]DVL1 strain, 368 
which showed ca. 3.7 log cycles higher (P ≤ 0.05) survival than the parental strain at 369 
700 MPa and 800 MPa. Nonetheless, the resistance of the [cyaA/rpoD]DVL1 mutant to all 370 
HHP treatments was still much lower (P ≤ 0.05) than that of DVL1.  371 
 372 





DVL1; Table S1) that could reproduce the 374 
resistance of DVL1 at the highest pressures (Fig. 2). In addition, all the four key 375 
mutations were combined in a single strain (denoted as QDVL1) in order to compare the 376 
effect of lacking only one of the alleles in the triple mutants. Moreover, to analyze in 377 
even more depth the HHP resistance of the triple and quadruple synthetic mutants in 378 









selective (VRBGA) medium to determine the extent of sublethal injury. The 380 
combination of the most HHP-protective single mutations in the strain T2
DVL1 (i.e., 381 
[cra/cyaA/rpoD]DVL1) surprisingly resulted in an equal (P > 0.05) resistance to that of 382 
the [cra/cyaA]DVL1 and [cra/rpoD]DVL1 strains and even lower (P ≤ 0.05) than that of the 383 
[cyaA/rpoD]DVL1 mutant at 700 MPa (Fig. 1 and 2). Furthermore, T2
DVL1 proved to be 384 




DVL1 mutants (containing [cra/aceA/rpoD]DVL1, 386 
[cra/cyaA/aceA]DVL1 and [cyaA/aceA/rpoD]DVL1 alleles, respectively) finally displayed 387 
similar (P > 0.05) inactivation than DVL1 at 700 MPa. However, the number of 388 
sublethally injured survivors of T3
DVL1 was ca. 93% higher (P ≤ 0.05) than that of 389 
DVL1, while T4
DVL1 actually incurred 81% lower (P ≤ 0.05) damaged cells. In fact, the 390 
increased HHP resistance of T4
DVL1 significantly stood up at 800 MPa, resulting in 37-391 
fold higher (P ≤ 0.05) survival than DVL1. Interestingly, compared to mutant T4
DVL1, 392 
the combination of the four alleles in the quadruple mutant (QDVL1) showed slightly 393 
lower (P > 0.05) resistance at 800 MPa and higher extent of sublethal damage at both 394 
700 MPa and 800 MPa.  395 
 396 
Overall, the simultaneous presence of three of any of the key mutant alleles could reach 397 
similar or even better levels of HHP resistance (at 800 MPa) than DVL1, except for the 398 
combination of [cra/cyaA/rpoD]DVL1, which even negatively affected the interaction 399 












Figure 2. Inactivation (log [N0/N]) of DVL1 and triple and quadruple synthetic mutants 404 
of MG1655 by HHP treatment (15 min) at different pressures (700 MPa and 800 MPa). 405 
Survivors were recovered on TSA (white bars) and VRBGA (black bars). The dotted 406 
line represents the limit of quantification (1,000 CFU/ml). Letters above each bar allow 407 
strains within the same panel and recovery condition to be statistically compared, with 408 
lowercase letter referring to recovery on TSA and capital letters referring to recovery on 409 
VRBGA. Strains are only significantly different (P ≤ 0.05) from each other when they 410 













 3.4. Evaluation of functional effect of key mutations 416 
We then focused on investigating the functional effect of each individual spontaneous 417 
mutation that was critical for HHP resistance development in DVL1. To examine the 418 
impact of the mutation in the 5’ UTR of rpoD locus, we measured levels of gene 419 
expression in the WT and rpoDDVL1 strains harbouring a rpoD-msfgfp transcriptional 420 
fusion. In addition, RpoD activity was assessed using the β-galactosidase reporter 421 
(Fischer et al., 1998; Fu et al., 2015), since expression of the lacZ gene (encoding the β-422 
glactosidase enzyme) is mediated by this sigma factor. Although the DVL1 mutation 423 
did not affect (P > 0.05) rpoD promoter activity, it did reduce (P ≤ 0.05) β-424 
galactosidase activity (Fig. 3A and B), suggesting that the mutant allele could incur an 425 
altered somehow posttransciptional regulation that in turn downregulates RpoD activity. 426 
Since reduced RpoD levels can affect the competition among sigma factors for the RNA 427 
polymerase (Gao et al., 2016; Jishage et al., 2002), we evaluated whether the rpoDDVL1-428 
mediated HHP resistance phenotype could stem from alterations in the regulatory 429 
function of the RpoS or RpoH sigma factors. In fact, quantifying GFP expression from 430 
the bolA promoter (using the pFPV-PbolA-gfp reporter plasmid (Gayán et al., 2016)) and 431 
dnaK promoter (using the pPFV-PdnaK-gfp reporter plasmid (Aertsen et al., 2004)) as a 432 
proxy of basal cellular RpoS and RpoH levels, respectively, showed that attenuated 433 
RpoD activity indeed boosted both RpoS- and RpoH-dependent responses (Fig. 4A and 434 
B, respectively). Nevertheless, RpoH activity within the DVL1 strain still outperformed 435 











Figure 3. (A) Average cellular fluorescence derived from rpoD-msfgfp transcriptional 439 
fusion and (B) β-galactosidase activity in MG1655 (WT) and its synthetic rpoDDVL1 440 
mutant. Letters above each bar allow strains within the same panel to be statistically 441 
compared. Strains are only significantly different (P ≤ 0.05) from each other when they 442 
don’t share the same letter. AU: arbitrary units. In Fig. A, the number of cells of the WT 443 










Figure 4. Fluorescence derived from (A) pFPV-PbolA-gfp (encoding the E. coli MG1655 446 
bolA promoter upstream of gfp; as a proxy of RpoS activity) and (B) pFPV-Pdnak-gfp 447 
(encoding the E. coli MG1655 dnaK promoter upstream of gfp; as a proxy of RpoH 448 
activity) in DVL1, MG1655 (WT) and the indicated synthetic mutants of MG1655. 449 
Letters above each bar allow strains to be statistically compared. Strains are only 450 
significantly different (P ≤ 0.05) from each other when they don’t share the same letter.. 451 
 452 
 453 
To determine the functionality of craDVL1 and aceADVL1 encoded proteins, we compared 454 
the impact of the corresponding wild-type, mutant (i.e., craDVL1 and aceADVL1) and 455 
null/deletion alleles (i.e., ∆cra and ∆aceA) on the ability to grow on glucose (as a 456 









repressor-activator or the isocitrate lyase impairs the use of acetate (Kim et al., 2018; 458 
Maloy and Nunn, 1982). As shown in Table 2, the craDVL1 strain, like the ∆cra mutant, 459 
showed a growth defect on acetate but not on glucose. In agreement, the increased HHP 460 
resistance of the ∆cra mutant compared to the WT strain at 600 MPa equalled (P > 461 
0.05) that of the craDVL1 mutant (Fig. 5). In order to further confirm that compromised 462 
Cra activity was causally linked to the craDVL1 and ∆cra phenotypes, each mutant and 463 
the WT strain were equipped with a plasmid-borne copy of the parental cra gene (using 464 
pACYC184-craWT), and with the pACYC184 vector as a control. The presence of 465 
pACYC184-craWT in the craDVL1 and ∆cra mutants restored  their ability to grow on 466 
acetate (Table 2) and decreased their HHP resistance to the same levels (P > 0.05) as the 467 
WT strain containing the pACYC184-craWT plasmid (Fig. S1A). Measuring PbolA and 468 
PdnaK activity, we observed slightly decreased (P ≤ 0.05) RpoS activity levels in the 469 
mutants compared to the WT strain but equal (P > 0.05) RpoH activity levels (Fig. 4). 470 
Indeed, the increased RpoS activity derived from poDDVL1 mutation was attenuated in 471 
the reconstructed mutants carrying the craDVL1 allele (i.e., T1
DVL1, T3
DVL1 and QDVL1), 472 






































Table 2. Growth of E. coli MG1655 (WT) and its derivatives on M9-glucose (0.5%; as 503 
a control) and M9-acetate (1.0%) after incubation at 37ºC for 48 h. Growth of each 504 
strain on each medium was scored from ++++ (WT growth) to − (no growth). 505 
 506 
Strain M9-glucose M9-acetate  
WT ++++ ++++ 
WT pACYC184 ++++ ++++ 
WT pACYC184-craWT ++++ ++++ 
WT pACYC184-aceBAWT ++++ ++ 
∆cra ++++ + 
∆cra pACYC184 ++++ + 
∆cra pACYC184-craWT ++++ ++++ 
craDVL1 ++++ + 
craDVL1 pACYC184 ++++ + 
craDVL1 pACYC184-craWT ++++ ++++ 
∆aceA ++++ - 
∆aceA pACYC184 ++++ - 
∆aceA pACYC184-aceBAWT ++++ ++ 
aceADVL1 ++++ - 
aceADVL1 pACYC184 ++++ - 
aceADVL1 pACYC184-aceBAWT ++++ ++ 
∆cyaA ++++ - 










Figure 5. Inactivation (log [N0/N]) of MG1655 (WT) and indicated synthetic mutants of 508 
MG1655 by HHP treatment (15 min) at 600 MPa. Survivors were recovered on TSA. 509 
The dotted line represents the limit of quantification (1,000 CFU/ml). Letters above 510 
each bar allow strains to be statistically compared. Strains are only significantly 511 
different (P ≤ 0.05) from each other when they don’t share the same letter.  512 
 513 
 514 
Both aceADVL1 and ∆aceA strains grew poorly on acetate, which agreed with the likely 515 
loss-of-function truncation found in the aceADVL1 allele. However, the deletion of aceA 516 
in the WT strain resulted in a 1.0 log cycle higher (P ≤ 0.05) HHP inactivation (600 517 
MPa) than in the strain harbouring the truncated AceA protein (Fig. 5). 518 
Complementation of both mutants by a plasmid-borne aceBAWT copy (using 519 
pACYC184-aceBAWT) enabled them to grow on acetate but to a lower degree than the 520 
WT strain (Table 2). However, overexpression of aceBAWT in the WT strain also 521 
impaired the growth on acetate, indicating that aceBA overdose attenuated fitness for 522 

























































∆aceA mutants with a native aceBAWT copy decreased (P ≤ 0.05) their HHP sensitivity 524 
by ca. 2.9 log cycles, as well as the survival of the WT strain but in a lower extent (2.0 525 
log cycles; Fig. S1B). Interestingly, while aceADVL1 and ∆aceA mutations did not (P > 526 
0.05) affect levels of PbolA activity (Fig. 4A), the aceA
DVL1
 allele caused a 1.9-fold higher 527 
(P ≤ 0.05) PdnaK activity compared to the WT and ∆aceA alleles (Fig. 4B). However, the 528 
large (ca. 2.9-fold) increase in PdnaK activity as observed in DVL1 was only reached 529 
when combining the [cyaA/aceA/rpoD]DVL1 alleles in the triple mutant T4
DVL1 and, by 530 
extension, in the quadruple (QDVL1) mutant (Fig. 4). 531 
 532 
Regarding the cyaA mutation, we previously noted that DVL1 had compromised 533 
cAMP/CRP regulation likely due to the loss-of-function mutation incurred in the cyaA 534 
gene (Gayán et al., 2017a). Consistent to our expectations, synthetic reconstruction of 535 
the cyaADVL1 allele in the parental MG1655 strain reduced the ability of acetate usage 536 
(Table 2) and provided similar levels (P > 0.05) of HHP protection (600 MPa; Fig 5) 537 
than the complete gene deletion (i.e., ∆cyaA strain). As anticipated (Gayán et al., 2017a; 538 
Vanlint et al., 2013a), neither cyaADVL1 nor ∆cyaA mutation increased basal RpoS or 539 
RpoH activity of the parental strain (Fig.4). 540 
 541 
Therefore, deletion of cra, aceA and cyaA genes could mimic the phenotypes of the 542 
corresponding spontaneous mutant alleles, although the extent of increased HHP 543 
resistance provided by the aceADVL1 mutation was higher than that of the aceA deletion.  544 
 545 
3.5. Clean synthetic reconstruction of extreme HHP resistance in E. coli  546 
Finally, we aimed to synthetically reconstruct an extremely HHP resistant E. coli 547 









triple combinations of mutations carried by T1
DVL1, T3
DVL1 and T4
DVL1 strains (which 549 
equalled or surpassed HHP resistance of DVL1; Fig. 2), but completely deleting those 550 
genes carrying loss-of-function mutations (i.e., cra, aceA and cyaA) (Fig. 6). Since 551 
rpoD is an essential gene for cell viability (Baba et al., 2006), the SNP in its 5’ UTR 552 
had to be identically reproduced for properly compromised RpoD activity. The 553 
combination of rpoDDVL1 with the cra and aceA deletions (i.e., T1
DVL1 ∆cra ∆aceA 554 
strain) showed ca. 0.7 log cycle lower (P ≤ 0.05) survival than T1
DVL1 at 800 MPa, while 555 
incorporating the truncated AceA protein of DVL1 (i.e., T1
DVL1 ∆cra strain) resulted in 556 
similar (P > 0.05) survival and sublethal injury levels than DVL1 and T1
DVL1 at 700 557 
MPa and 800 MPa. Regarding the combination of cra, cyaA and aceA mutations (i.e., 558 
T3
DVL1 derivatives), simultaneous deletion of the three genes resulted in ca. 54-fold 559 
lower (P ≤ 0.05) resistance than in T3
DVL1 and DVL1 at 800 MPa. Removal of the cyaA 560 
or aceA gene in the T3
DVL1 ∆cra background led to highly HHP sensitive strains as well, 561 
and only the combination of ∆cra with the cyaA and aceA spontaneous mutations 562 
reached the same (P > 0.05) degree of survival than in T3
DVL1. In agreement, the 563 
resistance of strains harboring the rpoDDVL1 allele and the deletion of both cyaA and 564 
aceA genes, the deletion of cyaA gene with aceADVL1 allele or the deletion of aceA gene 565 
with cyaADVL1 allele (i.e., T4
DVL1 ∆cyaA ∆aceA, T4
DVL1 ∆cyaA and T4
DVL1 ∆aceA, 566 
respectively) was markedly lower (P ≤ 0.05) than T4
DVL1, indicating that the CyaA and 567 
AceA truncated proteins provided better fitness for HHP resistance than their absence.  568 
 569 
As such, the phenotype of DVL1 could be most cleanly reconstructed by T1
DVL1 ∆cra 570 
(i.e., deleting cra and preserving the rpoDDVL1 and aceADVL1 alleles) or T3
DVL1 ∆cra (i.e., 571 
deleting cra and preserving the cyaA DVL1 and aceA DVL1 alleles). Nevertheless, when 572 
taking sublethal injury into account as well, the T3









higher (P ≤ 0.05) sublethally injured cells than DVL1 after applying the 700 MPa 574 
treatment (Fig. 6). The T4
DVL1 mutant (containing [cyaA/aceA/rpoD]DVL1 alleles), 575 
however, remained outperforming all other synthetic reconstructed strains (and even 576 
DVL1 itself) in terms of HHP resistance and suppression of sublethal injury.  577 
578 
Figure 6. Inactivation (log [N0/N]) of DVL1, MG1655 (WT) and indicated synthetic 579 
mutants of MG1655 by HHP treatment (15 min) at different pressures (700 MPa and 580 
800 MPa). Survivors were recovered on TSA (white bars) and VRBGA (black bars). 581 
The dotted line represents the limit of quantification (1,000 CFU/ml). Letters above 582 
each bar allow strains within the same panel and recovery condition to be statistically 583 
compared, with lowercase letter referring to recovery on TSA and capital letters 584 
referring to recovery on VRBGA. Strains are only significantly different (P ≤ 0.05) 585 











4. Discussion 589 
Next to metabolic engineering, the building of stress-resistant microbial chassis for 590 
applications in bioprocessing under inhospitable conditions or environments is gaining 591 
increased attention. As such, the genetic basis for engineering acid-, osmotic-, heat-, and 592 
solvent-robust microbial chassis has already been established (Appukuttan et al., 2015; 593 
de Siqueira et al., 2020; Jia et al., 2016; Lennen and Herrgård, 2014; Mukhopadhyay, 594 
2015; Swings et al., 2017). However, despite the biotechnological potential of HHP 595 
(Aertsen et al., 2009; Speranza, 2020), only little progress has been made on 596 
engineering HHP-robust microbial chassis because of the still cryptic multitarget impact 597 
of HHP on microbial physiology. In this investigation, we therefore embarked in 598 
analyzing the genome of the extremely HHP resistant DVL1 mutant obtained by 599 
directed evolution (Vanlint et al., 2011), and used this knowledge to synthetically 600 
engineer E. coli chassis capable of withstanding pressures of 600-800 MPa. 601 
  602 
By comparative genome sequencing and single reconstruction of each mutation found in 603 
DVL1, we first identified four key mutations (craDVL1, cyaADVL1, aceADVL1 and 604 
rpoDDVL1) causally linked to increased HHP resistance. However, the resistance of 605 
DVL1 to the highest pressures could only be reproduced by combining as a minimum 606 
three specific mutations, and one of the triple mutants (T4
DVL1, carrying the 607 
[cyaA/aceA/rpoD]DVL1 alleles) even managed to surpass this resistance. On the contrary, 608 
the combination of the most HHP-protective individual alleles ([cra/cyaA/rpoD]DVL1, 609 
carried by T2
DVL1) curiously resulted in antagonistic epistatic interactions, although such 610 
effect was alleviated when the four mutations were combined. However, we cannot 611 









beneficial for the intermediate resuscitation and growth steps imposed on DVL1 during 613 
the selection regime (Vanlint et al., 2011).  614 
 615 
Analysing the functional effect of each allele, we found that the rpoDDVL1 mutation, 616 
lying in the 5’ UTR of rpoD (Lupski et al., 1984; Yajnik and Godson, 1993) downtuned 617 
RpoD activity, thereby shifting the competition among sigma factors for binding to the 618 
RNA polymerase core in favour of RpoS and RpoH activity. Previous investigations 619 
have also demonstrated that acquisition of attenuating mutations in the rpoD ORF 620 
increase activity of stress-related sigma factors and consequently stress tolerance (Gao 621 
et al., 2016; Tenaillon et al., 2012; Zhang et al., 2015a). In fact, rpoDmutations have 622 
been frequently and independently found in mutants obtained by adaptive evolution 623 
towards growth tolerance under thermal and acid stress in E. coli (Harden et al., 2015; 624 
Tenaillon et al., 2012). Accordingly, most of our E. coli ATCC 43888 (serovar 625 
O157:H7) mutants previously selected for increased HHP or heat resistance displayed 626 
upregulated RpoS and/or RpoH activity without their encoding genes and promoters 627 
being mutated (Gayán et al., 2016; Vanlint et al., 2013b). Therefore, besides possible 628 
mutations that can affect the plethora of factors involved in RpoS and RpoH regulation 629 
(Battesti et al., 2011; Roncarati and Scarlato, 2017), changes in RpoD activity and 630 
therefore sigma factor balance can be an alternative pathway to acquire HHP resistance. 631 
To the best of our knowledge, this is the first described mutation in the 5’ UTR of the 632 
rpoD gene leading to an attenuated RpoD activity. Therefore, from a biotechnological 633 
point of view, rewriting this region may be a subtle and appropriate route to 634 
synthetically increase stress tolerance without modifying RpoD affinity for certain 635 









2019). However, further research is first necessary to decipher the role of the upstream 637 
non-coding region of rpoD in the regulation of the sigma factor.  638 
 639 
In addition, we corroborated that downregulation of cAMP/CRP activity is one of the 640 
most HHP-protective determinants in DVL1. The cAMP/CRP complex controls 641 
pleiotropic cellular functions, including non-glucose carbon utilization, central 642 
metabolic pathways and stress responses (Gosset et al., 2004; Shimada et al., 2011a), 643 
which hampers the identification of components truly involved in HHP resistance. 644 
However, it was shown that the HHP resistance provided by the cyaADVL1 allele is not 645 
modulated by the RpoS response (Gayán et al., 2017a), and even can complement the 646 
increase in resistance provided by upregulating RpoS and RpoH activity. It is 647 
noteworthy that complete deletion of the cyaA gene impaired the HHP resistance of the 648 
strongest strains harbouring the cyaADVL1 allele (i.e., T3
DVL1 ∆cra vs. T3
DVL1 ∆cra 649 
∆cyaA, and T4
DVL1 vs. T4
DVL1 ∆cyaA), despite the fact that it provided similar levels of 650 
resistance than the spontaneous mutant allele in the parental strain. This fact implies 651 
that the residual activity of the truncated CyaA or the mere presence of the inactive 652 
protein might improve the epistatic interactions among key mutations of DVL1 for HHP 653 
resistance.  654 
 655 
Besides cAMP/CRP downregulation, we encountered other mutations affecting central 656 
metabolism that are important for HHP resistance. The loss-of-function of Cra provided 657 
similar levels of pressure resistance than cAMP/CRP inactivation. Cra represses 658 
expression of genes involved in glycolytic pathways by sensing the concentration of 659 
fructose-1,6-bisphosphate (FBP) and fructose-1-phosphate (F1P), and activates 660 









of the tricarboxylic acid (TCA) cycle, electron transfer, glyoxylate shunt and 662 
gluconeogenesis (Saier and Ramseier, 1996; Shimada et al., 2011b). In addition, a 663 
number of stress response genes are putative targets of the cra regulatory network 664 
(Shimada et al., 2011b; Son et al., 2011). However, cra deletion mutants in E. colihave 665 
shown increased sensitivity to other stresses such as hyperosmolarity, alcohols and 666 
oxidative agents (Egoburo et al., 2018; Son et al., 2011). It is well known that changes 667 
in central metabolism impact RpoS activity and by extension stress resistance (Battesti 668 
et al., 2015; Gayán et al., 2019). Nonetheless, like in the case of cAMP/CRP 669 
downregulation, the role of Cra inactivation in increased HHP resistance was probably 670 
not mediated by RpoS and RpoH responses, and even reduced activity of RpoS-671 
dependent promoters. Therefore, the beneficial effects derived from Cra downregulation 672 
might predominate over the compromised RpoS activity that it causes. 673 
 674 
Despite the extensive overlap between the Cra and cAMP/CRP regulons, identification 675 
of common effector genes for increased HHP resistance is still complicated. Firstly, it 676 
has been evidenced that Cra positively regulates expression of the crp gene (Shimada et 677 
al., 2011b; Zhang et al., 2014). However, the fact that combining cra and cy A loss-of-678 
function mutations provided higher HHP resistance than the single mutations, rules out 679 
that Cra inactivation exerts its effect solely by cAMP/CRP downregulation. Secondly, 680 
both transcriptional regulators govern together the expression of several metabolic 681 
pathway genes, but generally in opposite directions (Kim et al., 2018; Shimada et al., 682 
2011a; Shimada et al., 2011b). Indeed, it has been demonstrated that the global central 683 
metabolism of exponentially growing cells is mainly regulated by Cra and CRP and 684 
their regulatory metabolites, and that the dominance among them actually depends on 685 









al., 2017; Li et al., 2014). Nevertheless, RpoS is also involved in the regulation of 687 
central metabolic changes occurring at the entrance of stationary phase (Li et al., 2014; 688 
Rahman et al., 2006), and therefore the imbalance among sigma factors mediated by the 689 
rpoDDVL1 allele could also affect possible Cra and cAMP/CRP targets. It should be also 690 
considered that other regulators can directly or indirectly participate in the control of 691 
many genes shared by the Cra, cAMP/CRP and stress-related sigma regulons. 692 
Therefore, a more complex approach encompassing transcriptomic, proteomic and/or 693 
metabolomic profiling will be required to trace back effector genes, molecules and 694 
metabolic routes involved in the extensive resistance of the reconstructed mutants. 695 
 696 
Intriguingly, the aceBA genes (encoding the malate synthase and isocitrate lyase acting 697 
in the second and first step of the glyoxylate shunt, respectively) are one of the co-698 
regulated loci by Cra and cAMP/CRP. In addition, expression of aceAB genes is 699 
affected by the interplay between RpoD and RpoS sigma factors (Rahman et al., 2006; 700 
Yamamoto and Ishihama, 2003). Regardless of the direction of aceAB regulation in the 701 
strains carrying mutations downregulating Cra, CyaA and/or RpoD activity, all the best 702 
reconstructed HHP-resistant mutants harboured a deleterious mutation in the aceA gene 703 
shutting down the glyoxylate shunt. The glyoxylate cycle serves to bypass the CO2-704 
generating steps of the TCA cycle, thus allowing the accumulation of intermediate 705 
gluconeogenic substrates and the reduction of NADH levels and the electron flux, 706 
which constitute an important defence mechanism against oxidative stress (Rui et al., 707 
2010).  However, the truncated AceA of DVL1 provided higher HHP protection than 708 
the loss of the complete protein. The presence of the aceADVL1 allele, but not the gene 709 
deletion, coincided with upregulated heat shock proteins, which has been suggested to 710 









Therefore, cryptic upregulation of the heat shock response, together with the shutdown 712 
of the glyoxylate shunt, might explain the aceADVL1 phenotype. However, the increased 713 
dnaK expression in DVL1 was only reached when combining at least aceADVL1, 714 
rpoDDVL1 and cyaADVL1 mutations, even though the latter allele could not change on its 715 
own RpoH activity. 716 
 717 
In this study, we revealed the genetic basis underlying extreme HHP-resistance in E. 718 
coli. We also shed light on the physiological mechanisms underlying each key mutation 719 
and their interactions in the reconstructed HHP-resistant mutants, signalling the coupled 720 
effect of cAMP/CRP downregulation, Cra inactivation, RpoS and RpoH upregulation 721 
and/or shutdown of the glyoxylate shunt on their phenotypes. These genetic and 722 
physiological insights in E. coli HHP-resistance can in the future support the targeted 723 
engineering of HHP resistant microbial chassis, and can also serve as a benchmark to 724 
understand and predict the broad variations in HHP-resistance that are especially 725 
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• The genome of an extreme HHP-resistant E. coli mutant and its parent were 
analyzed. 
• Four identified mutations were causally linked to increased HHP resistance. 
• HHP-resistant strains were engineered by combining some of the three 
mutations. 
• Decreased cAMP/CRP, Cra, and/or AceA activity, and increased RpoH and/or 
RpoS activity, explained the increased HHP resistance in the mutants. 
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